biopharm solutions limited
biopharm solutions limited Company Information
Group Structure
View All
Industry
Other business support service activities n.e.c.
Registered Address
41 kingston street, cambridge, CB1 2NU
Website
www.biopharmsolutions.combiopharm solutions limited Estimated Valuation
Pomanda estimates the enterprise value of BIOPHARM SOLUTIONS LIMITED at £58.2k based on a Turnover of £147.9k and 0.39x industry multiple (adjusted for size and gross margin).
biopharm solutions limited Estimated Valuation
Pomanda estimates the enterprise value of BIOPHARM SOLUTIONS LIMITED at £204.1k based on an EBITDA of £70.8k and a 2.88x industry multiple (adjusted for size and gross margin).
biopharm solutions limited Estimated Valuation
Pomanda estimates the enterprise value of BIOPHARM SOLUTIONS LIMITED at £122.4k based on Net Assets of £57.4k and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biopharm Solutions Limited Overview
Biopharm Solutions Limited is a dissolved company that was located in cambridge, CB1 2NU with a Companies House number of 10389545. It operated in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in September 2016, it's largest shareholder was sally steeden with a 100% stake. The last turnover for Biopharm Solutions Limited was estimated at £147.9k.
Upgrade for unlimited company reports & a free credit check
Biopharm Solutions Limited Health Check
Pomanda's financial health check has awarded Biopharm Solutions Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
5 Weak
Size
annual sales of £147.9k, make it smaller than the average company (£2.4m)
- Biopharm Solutions Limited
£2.4m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Biopharm Solutions Limited
- - Industry AVG
Production
with a gross margin of 17.2%, this company has a higher cost of product (37.8%)
- Biopharm Solutions Limited
37.8% - Industry AVG
Profitability
an operating margin of 47.9% make it more profitable than the average company (5.5%)
- Biopharm Solutions Limited
5.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (20)
1 - Biopharm Solutions Limited
20 - Industry AVG
Pay Structure
on an average salary of £42.1k, the company has an equivalent pay structure (£42.1k)
- Biopharm Solutions Limited
£42.1k - Industry AVG
Efficiency
resulting in sales per employee of £147.9k, this is equally as efficient (£136.7k)
- Biopharm Solutions Limited
£136.7k - Industry AVG
Debtor Days
it gets paid by customers after 163 days, this is later than average (42 days)
- Biopharm Solutions Limited
42 days - Industry AVG
Creditor Days
its suppliers are paid after 26 days, this is quicker than average (34 days)
- Biopharm Solutions Limited
34 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Biopharm Solutions Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Biopharm Solutions Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 13.3%, this is a lower level of debt than the average (65%)
13.3% - Biopharm Solutions Limited
65% - Industry AVG
BIOPHARM SOLUTIONS LIMITED financials
Biopharm Solutions Limited's latest turnover from February 2020 is estimated at £147.9 thousand and the company has net assets of £57.4 thousand. According to their latest financial statements, Biopharm Solutions Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Feb 2020 | Aug 2018 | Aug 2017 | |
|---|---|---|---|
| Turnover | |||
| Other Income Or Grants | |||
| Cost Of Sales | |||
| Gross Profit | |||
| Admin Expenses | |||
| Operating Profit | |||
| Interest Payable | |||
| Interest Receivable | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Dividends Paid | |||
| Retained Profit | |||
| Employee Costs | |||
| Number Of Employees | 1 | 1 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Feb 2020 | Aug 2018 | Aug 2017 | |
|---|---|---|---|
| Tangible Assets | 560 | ||
| Intangible Assets | |||
| Investments & Other | |||
| Debtors (Due After 1 year) | |||
| Total Fixed Assets | 560 | ||
| Stock & work in progress | |||
| Trade Debtors | 66,188 | 102,898 | |
| Group Debtors | |||
| Misc Debtors | |||
| Cash | |||
| misc current assets | |||
| total current assets | 66,188 | 102,898 | |
| total assets | 66,188 | 103,458 | |
| Bank overdraft | |||
| Bank loan | |||
| Trade Creditors | 8,807 | 30,989 | |
| Group/Directors Accounts | |||
| other short term finances | |||
| hp & lease commitments | |||
| other current liabilities | |||
| total current liabilities | 8,807 | 30,989 | |
| loans | |||
| hp & lease commitments | |||
| Accruals and Deferred Income | |||
| other liabilities | |||
| provisions | |||
| total long term liabilities | |||
| total liabilities | 8,807 | 30,989 | |
| net assets | 57,381 | 72,469 | |
| total shareholders funds | 57,381 | 72,469 |
| Feb 2020 | Aug 2018 | Aug 2017 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | |||
| Depreciation | |||
| Amortisation | |||
| Tax | |||
| Stock | |||
| Debtors | 66,188 | 102,898 | |
| Creditors | 8,807 | 30,989 | |
| Accruals and Deferred Income | |||
| Deferred Taxes & Provisions | |||
| Cash flow from operations | |||
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | |||
| cash flow from investments | |||
| Financing Activities | |||
| Bank loans | |||
| Group/Directors Accounts | |||
| Other Short Term Loans | |||
| Long term loans | |||
| Hire Purchase and Lease Commitments | |||
| other long term liabilities | |||
| share issue | |||
| interest | |||
| cash flow from financing | |||
| cash and cash equivalents | |||
| cash | |||
| overdraft | |||
| change in cash |
biopharm solutions limited Credit Report and Business Information
Biopharm Solutions Limited Competitor Analysis
Perform a competitor analysis for biopharm solutions limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other undefined companies, companies in CB1 area or any other competitors across 12 key performance metrics.
biopharm solutions limited Ownership
BIOPHARM SOLUTIONS LIMITED group structure
Biopharm Solutions Limited has no subsidiary companies.
Ultimate parent company
BIOPHARM SOLUTIONS LIMITED
10389545
biopharm solutions limited directors
Biopharm Solutions Limited currently has 1 director, Ms Sally Steeden serving since Sep 2016.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Sally Steeden | 47 years | Sep 2016 | - | Director |
P&L
February 2020turnover
147.9k
0%
operating profit
70.8k
0%
gross margin
17.3%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2020net assets
57.4k
0%
total assets
66.2k
0%
cash
0
0%
net assets
Total assets minus all liabilities
biopharm solutions limited company details
company number
10389545
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
September 2016
age
9
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
February 2020
previous names
N/A
accountant
-
auditor
-
address
41 kingston street, cambridge, CB1 2NU
Bank
-
Legal Advisor
-
biopharm solutions limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to biopharm solutions limited.
biopharm solutions limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOPHARM SOLUTIONS LIMITED. This can take several minutes, an email will notify you when this has completed.
biopharm solutions limited Companies House Filings - See Documents
| date | description | view/download |
|---|
